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Summary
Objective: Continued civil war and political instability in Afghanistan have lead to a huge influx of
refugees into the neighboring provinces in Pakistan. This study was conducted to estimate
seroprevalence of hepatitis B and to identify potential risk factors for hepatitis B virus (HBV)
transmission among the refugees living in the camps of Balochistan Province, Pakistan.
Methods: A cross-sectional survey of hepatitis B surface antigen (HBsAg) was conducted during
October 2003. We obtained the registration list to select families randomly from the refugee
camps. A husband, wife and one of their children, selected at random, were enrolled in the study.
Study subjects with positive laboratory results for HBsAg were compared with those who were
negative for HBsAg.
Results: Field workers interviewed 301 families with a total of 903 study subjects. Blood
specimens of 75 study subjects (8.3%, 95% CI 6.6—10.3) were positive for HBsAg. There were
37 husbands (12.3%, 95% CI 7.2—14.4) and 21wives (7.0%, 95% CI 4.5—10.6) positive for HBsAg. Out
of 301 children, 17 (5.6%, 95% CI 3.4—9.1) were positive for HBsAg. Receiving more than ten
injections during the previous year increased the risk of HBV infection (OR 3.5, 95% CI 1.8—6.7). A
child positive for HBsAg was more likely to have a positive parent compared to an HBsAg negative
child (OR 5.7, 95% CI 2.0—16.5).
Conclusion: Hepatitis B is highly endemic among Afghan refugees living in these camps. Unsafe
injection practices will continue to cause a steady increase in the magnitude of this health
problem until appropriate control measures are taken. The possibility of mother-to-child
transmission underscores the need to include vaccination against hepatitis B as part of routine
immunization in this population.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.* Corresponding author. Tel.: +93 70252650
E-mail addresses: arshadwho@yahoo.com, quddusa@afg.emro.who.int (A. Quddus).
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Infection with the hepatitis B virus (HBV) is a major public
health problem worldwide, and HBV-related complications in
chronically infected people account for approximately
600 000 deaths each year.1,2 HBV infection is endemic in
several parts of the world with moderate to high risk of
infection in the countries of Southeast Asia.3 In Pakistan,
the prevalence of HBV infection was found to be between 4%
and 10% among the general population in selected parts of
the country.4,5
The prevalence of HBV infection also varies in different
sub-groups of a population.6,7 The prevalence of chronic HBV
infection ranges up to 15% in the USA among refugees from
different parts of the world, with a prevalence rate of
hepatitis B surface antigen (HBsAg) of 4.1% among refugees
from Afghanistan.8
Continued civil war and political instability in Afghanistan
have lead to a huge influx of refugees into the neighboring
provinces of Pakistan. There were almost 190 000 refugees
living in 12 camps in the province of Balochistan before the
incident of September 11, 2001. The population of Afghan
refugees increased to 317 000 with the establishment of new
camps for refugees fleeing for shelter during the bombing of
Afghanistan in November 2001.
The United Nations High Commission for Refugees
(UNHCR) assists in provision of healthcare services to Afghan
refugees through the Project Directorate Health for Afghan
Refugees and various non-governmental organizations
(NGOs), with the support of UNICEF and WHO. Provision of
immunization services against vaccine-preventable diseases,
excluding hepatitis B, is one of the important components of
primary healthcare services at refugee camps.
Limited information regarding the magnitude of HBV
infection among Afghan refugees living in various parts of
Pakistan has been available. UNHCR perceived the need for
baseline information to help in designing an appropriate
control program. This study was conducted to estimate
seroprevalence of hepatitis B and to identify potential risk
factors for HBV transmission among the refugees living in the
camps of Balochistan Province, Pakistan.
Methods
There are 18 camps for Afghan refugees located in five
districts of Balochistan Province. Six of the 18 camps are
labeled as ‘new camps’ and were established in response to
refugee influx in November 2001. The remaining 12 ‘old
camps’ cater to Afghan refugees who have been arriving
since the time of the Russian invasion of Afghanistan in
1979. The population of Afghan refugees is approximately
190 000 and 127 000 in old and new camps, respectively.
To estimate the seroprevalence of HBsAg, a cross-sec-
tional survey was conducted during October 2003. To identify
the risk factors for transmission of HBV infection, study
subjects with positive laboratory results for HBsAg were
compared with those who were negative for HBsAg.
Families were selected as the sampling unit to assess the
overall magnitude and risk factors for HBV infection for each
sub-group within a family. A family was defined as husband,
wife and their unmarried children, all sharing one tent/house. To calculate an optimal sample size for the survey,
a prevalence of 7% was assumed. This assumption was based
on results of studies showing a range of prevalence from 4.5%
to 10% among different groups of population in Pakistan.4,5 If
the anticipated prevalence of HBsAg is ‘p’, then for a max-
imum difference of 3% from the true value (d), the following
formula was used to achieve a sample size (n) of 277 families
from a population (N) of almost 54 000 families with signifi-
cance level of 5%:
n ¼ NZ
2 pð1 pÞ
Z2 pð1 pÞ þ ðN  1Þd2
Accounting for non-response and missing information, an
increase by 10% led to a sample size of 304 families. Due
to budgetary constraints three members from each family
were sampled, husband, wife and one of their children.
Due to the existence of two different strata (old and new)
within the refugee camps, the total sample size was distrib-
uted into each stratum, proportional to their population size.
All the refugees living in the camps were registered with the
allocation of a specific serial number to each family unit. The
office of Directorate of Afghan Refugees maintains a com-
plete list of these Afghan families. Families in both old and
new camps were selected randomly from the registration list.
Afghan families living in the camps but not registered with
the Directorate of Afghan Refugees were excluded from the
study. Following selection of the families, the husband, wife
and one of their children, selected randomly from among the
unmarried children of any age, were enrolled in the study. In
the case of households with multiple families, one family was
selected randomly for the study. Team supervisors explained
the objectives and obtained verbal consent from the head of
the family before starting the interview and collection of
blood samples. Each team consisted of four members, two
female and one male interviewer, and one laboratory tech-
nician. Interviewers collected the relevant information by
administering a pre-designed questionnaire for each family
member. Information on sexual risk factors for HBV transmis-
sion was not collected. This is because of the very conserva-
tive society, with social and cultural sensitivity making it
difficult to obtain information on sexual behaviors outside of
marriage. Any family member not present at the time of
interview was approached again until all the information and
blood samples were collected. In the case of refusal, inter-
viewers approached the next closest family.
A one-step HBsAg test device of cassette style was used.
Micropipettes with disposable fine tips were used to dispense
three drops of centrifuged serum onto the sample well of the
cassette. The specimen migrates up through the absorbent
pad in the sample well. The test line region of the cassette is
coated with monoclonal and polyclonal antibodies which
conjugate to form antigen/antibody complex in the presence
of HbsAg, with the appearance of a distinct pink colored band
within 10—20 min in the test region of the cassette. Both
sensitivity and specificity of this qualitative immunoassay
test are 99%.
Point estimates of seroprevalence of HBsAg with 95%
confidence intervals (CI) were calculated for husbands, wives
and children. Age-specific seroprevalence with 95% CI was
also computed. To identify the risk factors for HBV antige-
nemia, univariate analyses for husbands and wives were
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Table 2 General characteristics of Afghan refugees living in
the camps of Balochistan Province, Pakistan
Characteristics Frequency
number
%
(n = 301)
Main language spoken in the family:
Pushto 280 93
Persian 18 6
Other 3 1
Place of residence in Afghanistan:
Southwestern region (Kandahar) 106 35
Central region (Kabul) 39 13
Southeastern region (Ghazni) 33 11
Western region (Mazar Sharif,
Kunduz)
45 15
Other 78 26
Living for more than three
years in the camp
196 65
Literate husbands 30 10
Literate wives 3 1
Preferred place of treatment:
BHU/hospital 151 50
General practitioner 141 47
Traditional healers 9 3
Preferred treatment for common illnesses:
Injection 138 46
Tablet 133 44
Syrup 30 10
Children who received three
doses of hepatitis B vaccine
3 1
(n = 903)
Age (years)
0—10 244 27
11—20 90 10
21—30 190 21
31—40 199 22
41—50 117 13
>50 63 7
Injection received for
last illness
605 67
Place injection received for last illness:
BHU/hospital 289 67carried out separately. The maximum likelihood estimates of
the odds ratio and exact 95% CI were calculated for each
variable of interest using Epi Info version 6.04 (CDC, Atlanta,
GA, USA). The reference group for each variable was deter-
mined by the category with minimal level of risk of HBV
infection. Logistic regression was used to carry out multi-
variate analysis and a single model was developed, including
husband and wife together, to control for confounders parti-
cularly by age and sex. Biological and statistical significance
was the basis of selection of risk factors for multivariate
analysis.
Results
Interviewers approached 309 families and interviewed 301
(97%) with a total of 903 study subjects. Blood specimens of
all study subjects were tested for HBsAg. Blood specimens of
75 study subjects (8.3%, 95% CI 6.6—10.3) were positive for
HBsAg. There were 37 husbands (12.3%, 95% CI 7.2—14.4) and
21 wives (7.0%, 95% CI 4.5—10.6) positive for HBsAg. The
mean age of HBsAg positive husbands was 40 years (range 22—
60 years) while the mean age of positive wives was 31 years
(range 16—50 years). Out of 301 children, 17 (5.6%, 95% CI
3.4—9.1) were positive for HBsAg. The mean age of positive
children was 6.5 years (range 3—24 years).
The age-specific rates for HBsAg seroprevalence among
Afghan refugees suggests that almost all the age groups were
affected and the prevalence rises gradually after the age of
10 years (Table 1).
Most of the study population (93%) was Pushto
speaking (Table 2) and had migrated from different parts
of Afghanistan. The duration of stay in camps varied widely.
Most of the study population (65%) was living in old refugee
camps while 35% had been there less than three years and
were living in the new refugee camps (Table 2). Most of the
husbands and wives (90% and 99% respectively) were illiter-
ate (Table 2).
The age structure of our study population is not reflective
of the age distribution among Afghan refugees. This is
because of the samplingmethodology where we only enrolled
husband, wife and one of their children, resulting in a
relatively small proportion in the 11—20 years age group
(Table 2).Private clinic 289 32
Home 542 60
More than three injections
received last month
163 18
More than 10 injections
received last year
226 25
Ever received blood transfusion 18 2
Ever donated blood 54 6
Surgically operated in past 72 8
Using IV drug on regular basis 9 1
Positive history of jaundice in past 172 19
Tattooing parts of body 406 45
BHU, basic health unit.
Table 1 Seroprevalence of HBsAg by age group among
Afghan refugees living in camps of Balochistan Province,
Pakistan
Age
(years)
Total
observations
HBsAg
positive
cases
Sero-prevalence
(%)
95% CI
0—5 119 7 5.9 2.4—11.9
6—10 130 6 4.6 1.7—9.7
11—15 40 2 5.0 0.9—15.5
16—20 38 3 7.9 1.6—21.3
21—30 191 17 8.9 5.2—13.8
31—40 199 21 10.6 6.6—15.7
41—50 119 13 10.9 5.9—17.9
>50 67 6 9.0 3.3—18.5
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Table 3 Univariate analysis of risk factors for HBV infection among Afghan refugees living in camps of Balochistan Province,
Pakistan
Risk factor Husband Wife
Frequency among Frequency among
HBsAg positive
% (n = 37)
HBsAg negative
% (n = 264)
Odds ratio
(95% CI)
HBsAg positive
% (n = 21)
HBsAg negative
% (n = 280)
Odds ratio
(95% CI)
Received treatment by
private practitioner
67 47 2.43 (1.1—5.4) 57 34 2.62 (1.0—7.4)
Ever received injection 89 95 0.44 (0.1—1.9) 95 97 0.67 (0.1—33.3)
Received injection for
last illness
51 41 1.84 (0.8—4.1) 71 69 1.14 (0.4—3.7)
Received >3 injections
last month
57 09 13.35 (5.7—31.3) 33 16 2.51 (1.0—7.1)
Received >10 injections
last year
13.5 02 7.88 (1.8—34.1) 29 12 2.95 (1.0—8.8)
HbsAg positive child 11 05 2.35 (0.5—8.2) 25 4.4 7.15 (1.7—25.7)
HBsAg positive husband — — — 11 06 1.84 (0.4—6.2)
Positive history of
jaundice in past
22 20 1.09 (0.4—2.7) 19 27 0.70 (0.16—2.2)
Ever attended health
education session
16 15 1.14 (0.4—3.0) 22 14 1.70 (0.5—5.1)
Tattooing any part
of body
41 48 0.74 (0.3—1.6) 71 77 0.72 (0.3—2.4)
Illiteracy 92 90 1.22 (0.3—5.4) — — —
Years stay in camp >3 54 52 1.07 (0.5—2.3) — — —
Barber preferred for
shaving
14 22 0.58 (0.2—1.6) — — —
Breastfeeding children
during infancy
— — — 91 96 0.43 (0.1—4.2)
Ear piercing for earrings — — — 95 99 0.22 (0.1—12.0)
Table 4 Multivariate analysis of risk factors for HBV infec-
tion among Afghan refugees living in camps of Balochistan
Province, Pakistan
Risk factors Adjusted
odds ratio
95% confidence
interval
Received injection
for last illness
1.40 0.5—4.0
Received >10 injections
last year
3.50 1.8—6.7
Received treatment
by private practitioner
1.80 1.0—3.5
HBsAg positive child 5.70 2.0—16.5The basic health unit or the hospital were the most
popular places to seek treatment for any illness. However,
a substantial proportion (47%) of the refugees preferred to
consult general practitioners who were practising in towns
outside the camps (Table 2). Forty-six percent of the study
population preferred an injection to treat common illnesses,
followed by tablets and syrup (Table 2). Sixty-seven percent
of the study population received an injection as a part of
treatment during their last illness. General practitioners, at
their private clinic, administered most (60%) of the recent
injections.
Two percent of our study population had received a blood
transfusion in the past (Table 2). Forty-three percent of these
blood recipients received blood from a relative, although 14%
received blood purchased from a medical store. Nineteen
percent of the study population had a history of jaundice.
Only one percent of Afghan children living in the camps had a
credible history of receiving at least three doses of vaccine
against hepatitis B (Table 2).
Afghan refugees who preferred to seek treatment from
private practitioners were more likely to be positive for
HBsAg compared to those who sought treatment at a hospital
or basic health unit in the camps (Table 3). For both husbands
and wives, receiving more than three injections during the
previous month or receiving more than ten injections during
the previous year, was associated with HBV infection
(Table 3). Children of HBsAg positive mothers were more
likely to be positive for HBsAg compared to the children ofHBsAg negative mothers (Table 3). The risk of HBV infection
among wives was not significantly associated with the HBsAg
status of their husbands. The duration of stay in the camps,
father’s education, breastfeeding and past history of jaun-
dice was not associated with HBV infection in our study
population (Table 3).
On multivariate analysis, receiving more than ten injec-
tions in the previous year increased the risk of HBV infection
(Table 4). Children positive for HBsAg were almost six times
more likely to have a positive parent compared to HBsAg
negative children (Table 4).
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Seroprevalence of HBsAg among Afghan refugees living in the
camps of Balochistan Province was 8.3% while the prevalence
among husband, wife and children were 12.3%, 7.0% and
5.6%, respectively. The prevalence of HBsAg in a population
largely depends on immunization coverage against hepatitis
B and prevalence of unsafe injection practices.9,10 Lack of
immunization services against hepatitis B in the refugees
camps and the preference for injections for common illnesses
(Table 2) are the main apparent factors leading to this high
level (>8%) of HBsAg prevalence in this Afghan refugee
population. The study among refugees arriving from different
parts of the world in the USA, found a seroprevalence of 4.1%
among Afghan refugees.8 Since most of the Afghan refugees
who left for the USAwere of higher socio-economic class with
probably better healthcare-seeking behavior, this could be
the reason for the comparatively lower estimates of HBsAg
seroprevalence among Afghan refugees arriving there.
A gradual increase in the seroprevalence of HBsAg after
the age of 10 years and up until 50 years, when the pre-
valence starts to decline, was found (Table 1). A gradual
increase in the prevalence of HBV infection up until the age of
40 years has also been observed in other studies.11—13 The
higher prevalence among older age groups could be due to
more frequent exposure to some of the risk factors for HBV
infection.
Receiving more than ten injections during the previous
year, for both husbands and wives, was an important risk
factor in this study (OR 3.5, 95% CI 1.8—6.7). The number of
injections received during the last year, though liable to
recall bias, is a surrogate of tendency for injection-prefer-
ence among the refugees and reflects the fact that risk of HBV
infection is higher among those who receive injections more
frequently. The risk of getting hepatitis B infection was also
high among those who sought treatment from private health-
care providers (Table 4), reflecting the fact that they con-
tributed in administeringmost of the injections to this Afghan
population. Different studies have found unsafe injection
practices as a major source of HBV transmission and other
blood-borne pathogens in many countries.10,14 The likelihood
of acquiring an infection on exposure to unsafe injection
depends on the transmissibility of the pathogen present. The
probability of becoming infected through an unsafe injection
also depends on the prevalence of blood-borne pathogens in
the population.15 Considering the transmissibility of HBV and
a high seroprevalence of HBsAg (8.3%) among Afghan refu-
gees, there is a high probability that the unsafe injection
practices will continue to cause a steady increase in the
number of unrecognized transmission chains of hepatitis B in
this refugee population, and will pose a substantial public
health problem until appropriate preventive measures are
taken. Increasing the awareness on the impact of unsafe
injections through regular health education sessions in the
camps and encouraging safe injection practices among
healthcare providers, particularly private practitioners,
can substantially reduce the burden of HBV infection16,17
in the refugee population.
The high risk of HBV infection among children of HBsAg
positive parents suggests that mother-to-child transmission is
also an important route for HBV transmission. Impact of
HBsAg status of mothers on the risk of HBV infection amongchildren (Table 3) and a high prevalence among children
below 5 years of age (5.9%) indicates a high probability of
transmission of infection from HBV-infected mother to baby
(perinatal transmission) among these Afghan children living
in the camps. Mother-to-child transmission has also been
identified as a major source of infection in many other
countries.11,18,19 We were unable to sample all the children
in a selected family, but child-to-child transmission within
the household setting may lead to higher HBsAg prevalence
among these Afghan children below 5 years of age, as has also
been observed in other studies.20—23 Child-to-child spread
usually involves contact with blood, saliva or skin sore secre-
tions through small breaks in the skin or mucous mem-
brane.24,25
In either case, the results of this study have important
public health implications, as the infection acquired during
infancy or early childhood has a very high carrier rate and
serious consequences including cirrhosis and hepatic carci-
noma.1,26 The high morbidity and mortality associated with
chronic HBV infection among Afghan refugees poses an addi-
tional burden to the population living in the camps, and to
the relatively weak healthcare system in the province. The
current vaccination program in the camps does not offer
protection against hepatitis B. There is an urgent need to
include vaccine against hepatitis B in the ongoing vaccination
program for children living in Afghan camps, following the
national policy on Expanded Program on Immunization. More-
over, limited information is available about the magnitude of
HBV infection in Afghanistan but since the refugees in the
camps belong to almost all regions of Afghanistan with typical
healthcare-seeking behavior, the results of this study can be a
proxy of HBV burden in Afghanistan, where the healthcare
services are almost nonexistent due to the civil war for more
than two decades.
There are important limitations to this study. It is possible
that HBsAg positive persons were ill more frequently because
of their chronic hepatitis infection, saw a practitioner more
frequently, and so received an injection more frequently.
Thus, they may have received more injections because they
were HBsAg positive rather than the injections preceding the
infection. However, unsafe injection practices are common in
Pakistan10 and unsafe injection practices are known to trans-
mit hepatitis B,14 so at least part of this association likely
results from unsafe injections causing hepatitis B infections.
Secondly, hepatitis B core antibody was not tested, which
would be a better marker of infection and a more efficient
means to evaluate transmission. However, HBsAg is a better
measure of the health burden, which was the primary objec-
tive of the study.
Another limitation is that, although HBV infection can be
transmitted efficiently through sexual intercourse,27 the role
of sexual behavior in transmission of hepatitis B infection was
not assessed. Even if this were an important route of trans-
mission, we would expect improved injection safety and
vaccination to reduce community transmission of hepatitis B.
In summary, the seroprevalence of HBsAg among Afghan
refugees living in camps of Balochistan Province is reflective
of a highly endemic population. Hepatitis B vaccination
should be included as a routine immunization in this popula-
tion. In addition, general preventive measures like health
education sessions in the camp and safe injection practices
among healthcare providers, particularly private healthcare
Prevalence of hepatitis B among Afghan refugees 247providers, should be the cornerstones of control measures
against hepatitis B infection in this community of refugees.
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